BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND LMNA, EMD2, 4000, ENSG00000160789, LGMD1B, LDP1, PRO1, LMNC, FPLD, CDDC, HGPS, P02545, LFP, IDC, CMD1A, CDCD1, LMN1, CMT2B1, FPL AND Treatment
49 results:

  • 1. Cervical cancer Screening: A Review.
    Perkins RB; Wentzensen N; Guido RS; Schiffman M
    JAMA; 2023 Aug; 330(6):547-558. PubMed ID: 37552298
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. TMEM41A overexpression correlates with poor prognosis and immune alterations in patients with endometrial carcinoma.
    Shi K; Liu XL; Guo Q; Zhang YQ; Fan ST; Dai L; Jiang N; Li D
    PLoS One; 2023; 18(7):e0285817. PubMed ID: 37478120
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Risk factors for recurrence of cervical intraepithelial neoplasia after loop electrosurgical excisional procedure in patients with positive margins.
    Oh SH; Lee KB; Shin JW; Lee SH
    J Obstet Gynaecol Res; 2023 Aug; 49(8):2102-2108. PubMed ID: 37277146
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study.
    De Jaeghere EA; Tuyaerts S; Van Nuffel AMT; Belmans A; Bogaerts K; Baiden-Amissah R; Lippens L; Vuylsteke P; Henry S; Trinh XB; van Dam PA; Aspeslagh S; De Caluwé A; Naert E; Lambrechts D; Hendrix A; De Wever O; Van de Vijver KK; Amant F; Vandecasteele K; Denys HG
    Cancer Immunol Immunother; 2023 Feb; 72(2):475-491. PubMed ID: 35960332
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Histotripsy for the treatment of uterine Leiomyomas: A Feasibility Study in Ex Vivo uterine Fibroids.
    Simon A; Robinson F; Anzivino A; Boyer M; Hendricks-Wenger A; Guilliams D; Casey J; Grider D; Valea F; Vlaisavljevich E
    Ultrasound Med Biol; 2022 Aug; 48(8):1652-1662. PubMed ID: 35641394
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Trastuzumab with carboplatin/paclitaxel for treatment of advanced stage and recurrent uterine papillary serous carcinoma: A cost-effectiveness analysis.
    Batman S; Bohn J; Weisenberger MW; Hersh A; Bruegl A; Caughey A; Winter W
    Gynecol Oncol; 2021 Jan; 160(1):214-218. PubMed ID: 33393480
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Sigmoid colon perforation after postoperative hypofractionated intensity-modulated radiation therapy in a cervical cancer patient.
    Kim H; Park W; Choi YL; Lee JW
    Cancer Rep (Hoboken); 2018 Oct; 1(3):e1129. PubMed ID: 32721073
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Pulse actinomycin D as first-line treatment of low-risk post-molar non-choriocarcinoma gestational trophoblastic neoplasia.
    Li L; Wan X; Feng F; Ren T; Yang J; Zhao J; Jiang F; Xiang Y
    BMC Cancer; 2018 May; 18(1):585. PubMed ID: 29792175
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Why do we continue to overtreat stage Ia carcinoma of the cervix?
    Buchanan T; Pierce JY; Graybill W; Kohler M; Creasman W
    Am J Obstet Gynecol; 2017 Oct; 217(4):413-417. PubMed ID: 28522321
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Cost-effectiveness of HPV vaccination in Belize.
    Walwyn L; Janusz CB; Clark AD; Prieto E; Waight E; Largaespada N
    Vaccine; 2015 May; 33 Suppl 1():A174-81. PubMed ID: 25919158
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Brain metastasis in gestational trophoblastic neoplasia: an update.
    Neubauer NL; Latif N; Kalakota K; Marymont M; Small W; Schink JC; Lurain JR
    J Reprod Med; 2012; 57(7-8):288-92. PubMed ID: 22838242
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Burden of invasive cervical cancer in North Carolina.
    Denslow SA; Knop G; Klaus C; Brewer NT; Rao C; Smith JS
    Prev Med; 2012; 54(3-4):270-6. PubMed ID: 22342290
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study.
    TOMBOLA Group
    BMJ; 2009 Jul; 339():b2549. PubMed ID: 19638648
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Women health behaviours regarding prevention and early detection of precancerous lesions and cervical carcinoma].
    Nowicki A; Borowa I; Maruszak M
    Ginekol Pol; 2008 Dec; 79(12):840-9. PubMed ID: 19175041
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Human papillomavirus, cervical cancer, and the vaccines.
    Tovar JM; Bazaldua OV; Vargas L; Reile E
    Postgrad Med; 2008 Jul; 120(2):79-84. PubMed ID: 18654072
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Cervical screening: why young women should be encouraged to be screened.
    Herbert A; Holdsworth G; Kubba AA
    J Fam Plann Reprod Health Care; 2008 Jan; 34(1):21-5. PubMed ID: 18201402
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. High-risk surgical stage 1 endometrial cancer: analysis of treatment outcome.
    Viani GA; Patia BF; Pellizzon AC; De Melo MD; Novaes PE; Fogaroli RC; Conte MA; Salvajoli JV
    Radiat Oncol; 2006 Aug; 1():24. PubMed ID: 16887018
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The role of interstitial brachytherapy using template in locally advanced gynecological malignancies.
    Agrawal PP; Singhal SS; Neema JP; Suryanarayan UK; Vyas RK; Rathi AK; Bahadur AK
    Gynecol Oncol; 2005 Oct; 99(1):169-75. PubMed ID: 16081150
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Pregnancy and delivery outcomes after loop electrosurgical excision procedure of cervical intraepithelial neoplasia].
    Qian DY; Zeng RH; Hong DH; Cen JM
    Zhonghua Fu Chan Ke Za Zhi; 2004 May; 39(5):326-8. PubMed ID: 15196416
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Early-onset sigmoid colon perforation during concurrent chemoradiation in a patient with cervical cancer.
    Lin H; Chang CL; Huang EY; Changchien CC
    Int J Gynecol Cancer; 2004; 14(2):381-3. PubMed ID: 15086743
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.